Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia
- PMID: 40403228
- DOI: 10.1182/blood.2025028723
Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia
Abstract
The autoimmune response driving hematopoietic stem and progenitor cell (HSPC) destruction in immune-mediated aplastic anemia (AA) remains incompletely understood. We previously identified a disease-specific immune cell network involving T, B, and myeloid cells. However, the interactions within this network, the interaction with the microenvironment, and the chronological events in AA development, remain unclear. In this study, we aimed to characterize the changes occurring during disease development and to define the interactions between potential autoreactive cells and their target. Using imaging mass cytometry, we analyzed bone marrow (BM) biopsies from patients with AA at diagnosis and after treatment with horse-derived anti-thymocyte globulin (hATG), and 6 controls. Within the hypocellular BM architecture, we identified lymphoid-dominant "immune hot spots" with high densities of proinflammatory lymphocytes, and macrophage-enriched hot spots that additionally contained activated macrophages in proximity to progenitors. These immune hot spots potentially represent sites in which the active immune response resulting in HSPC destruction takes place. In BM regions depleted of progenitors, effector cells with a differentiated phenotype remain. Our data indicate that HSPC destruction in AA is mediated by coordinated interactions among specific immune cell subpopulations. As the immune response progresses and HSPCs are depleted, the immune composition shifts, with activated T and B cells differentiating into terminally differentiated T cells and plasma cells. In patients with normalizing BM after hATG treatment, most immune hot spots were depleted, underscoring their potential pathogenic role. Collectively, our study visualizes the complex interactions among immune cell subpopulations and reveals, to our knowledge, for the first time, the order of events in the immune-mediated pathogenesis of AA.
© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Comment in
-
The landscape of disease: mapping aplastic anemia.Blood. 2025 Aug 21;146(8):905-906. doi: 10.1182/blood.2025029791. Blood. 2025. PMID: 40839257 No abstract available.
Similar articles
-
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2. Cochrane Database Syst Rev. 2013. PMID: 23881658 Free PMC article.
-
Platelets as a potential new immune coordinator in T cell-mediated aplastic anemia.Front Oncol. 2025 Jun 9;15:1568169. doi: 10.3389/fonc.2025.1568169. eCollection 2025. Front Oncol. 2025. PMID: 40552264 Free PMC article. Review.
-
The extra-islet pancreas supports autoimmunity in human type 1 diabetes.Elife. 2025 Apr 15;13:RP100535. doi: 10.7554/eLife.100535. Elife. 2025. PMID: 40232951 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials